S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
Log in
NASDAQ:HOLX

Hologic Stock Forecast, Price & News

$68.82
-1.68 (-2.38 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$67.71
Now: $68.82
$71.02
50-Day Range
$59.92
MA: $65.97
$70.92
52-Week Range
$26.49
Now: $68.82
$73.63
Volume2.23 million shs
Average Volume2.52 million shs
Market Capitalization$17.82 billion
P/E Ratio27.86
Dividend YieldN/A
Beta1.34
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, surgical products, and light-based aesthetic and medical treatment systems for women in the United States and internationally. The company offers Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for acute respiratory ailments. It also provides breast imaging and analytics, such as 2D and 3D mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company offers aesthetic treatment systems, as well as TempSure, a radio frequency energy-sourced platform, which offers non-surgical and surgical aesthetic treatments and procedures. Further, it offers NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Additionally, the company offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Read More
Hologic logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.65 out of 5 stars

Industry, Sector and Symbol

Industry X-ray apparatus & tubes
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:HOLX
CUSIP43644010
Phone508-263-2900
Employees6,478

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.37 billion
Cash Flow$4.31 per share
Book Value$7.91 per share

Profitability

Net Income$-203,600,000.00

Miscellaneous

Market Cap$17.82 billion
Next Earnings Date11/4/2020 (Confirmed)
OptionableOptionable
$68.82
-1.68 (-2.38 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HOLX News and Ratings via Email

Sign-up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Hologic (NASDAQ:HOLX) Frequently Asked Questions

How has Hologic's stock been impacted by COVID-19 (Coronavirus)?

Hologic's stock was trading at $43.78 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HOLX stock has increased by 57.2% and is now trading at $68.82.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Hologic?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Hologic
.

When is Hologic's next earnings date?

Hologic is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Hologic
.

How can I listen to Hologic's earnings call?

Hologic will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) released its earnings results on Wednesday, July, 29th. The medical equipment provider reported $0.75 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.37. The medical equipment provider earned $822.90 million during the quarter, compared to the consensus estimate of $622.96 million. Hologic had a net margin of 20.03% and a return on equity of 31.40%. The business's revenue for the quarter was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.63 earnings per share.
View Hologic's earnings history
.

What guidance has Hologic issued on next quarter's earnings?

Hologic updated its fourth quarter 2020 Pre-Market earnings guidance on Friday, September, 11th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.225-1.275 billion, compared to the consensus revenue estimate of $989 million.

What price target have analysts set for HOLX?

13 analysts have issued 12-month price targets for Hologic's stock. Their forecasts range from $43.00 to $85.00. On average, they anticipate Hologic's stock price to reach $67.15 in the next year. This suggests that the stock has a possible downside of 2.4%.
View analysts' price targets for Hologic
.

Are investors shorting Hologic?

Hologic saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 3,600,000 shares, an increase of 22.4% from the August 31st total of 2,940,000 shares. Based on an average daily trading volume, of 2,390,000 shares, the days-to-cover ratio is currently 1.5 days. Currently, 1.4% of the company's stock are short sold.
View Hologic's Short Interest
.

Who are some of Hologic's key competitors?

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), The Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

Who are Hologic's key executives?

Hologic's management team includes the following people:
  • Mr. Stephen P. MacMillan, Chairman, CEO & Pres (Age 56, Pay $3.27M)
  • Ms. Karleen M. Oberton, Chief Financial Officer (Age 50, Pay $1.06M)
  • Mr. John M. Griffin, Gen. Counsel (Age 59, Pay $1.12M)
  • Mr. Kevin R. Thornal, Division Pres of Diagnostic Solutions (Age 46, Pay $1.89M)
  • Mr. Peter J. Valenti III, Sr. Advisor to Chief Exec. Officer (Age 57, Pay $1.19M)
  • Dr. Jay A. Stein, Co-Founder, Chairman Emeritus, CTO & Sr. VP (Age 77)
  • Mr. Michael J. Watts, VP of Investor Relations & Corp. Communications
  • Ms. Allison P. Bebo, Sr. VP of HR (Age 51)
  • Mr. Jan Verstreken, Regional Pres for Europe, Middle East & Africa (EMEA) & Canada
  • Mr. Sanjay Prabhakaran, Regional Pres of Asia Pacific

What is Hologic's stock symbol?

Hologic trades on the NASDAQ under the ticker symbol "HOLX."

Who are Hologic's major shareholders?

Hologic's stock is owned by a variety of institutional and retail investors. Top institutional investors include Candriam Luxembourg S.C.A. (0.32%), Wedge Capital Management L L P NC (0.16%), DekaBank Deutsche Girozentrale (0.16%), Robeco Institutional Asset Management B.V. (0.15%), Kornitzer Capital Management Inc. KS (0.14%) and Atwood & Palmer Inc. (0.12%). Company insiders that own Hologic stock include Allison P Bebo, Benjamin Jordan Cohn, Christiana Stamoulis, John M Griffin, Karleen Marie Oberton, Peter J Valenti III, Sally Crawford and Stephen P Macmillan.
View institutional ownership trends for Hologic
.

Which major investors are selling Hologic stock?

HOLX stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Gateway Investment Advisers LLC, KBC Group NV, State of Alaska Department of Revenue, DekaBank Deutsche Girozentrale, Toronto Dominion Bank, State of New Jersey Common Pension Fund D, and Standard Life Aberdeen plc. Company insiders that have sold Hologic company stock in the last year include Benjamin Jordan Cohn, Christiana Stamoulis, John M Griffin, Karleen Marie Oberton, Peter J Valenti III, Sally Crawford, and Stephen P Macmillan.
View insider buying and selling activity for Hologic
.

Which major investors are buying Hologic stock?

HOLX stock was acquired by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., BNP Paribas Arbitrage SA, DNB Asset Management AS, Meritage Portfolio Management, Robeco Institutional Asset Management B.V., Dupont Capital Management Corp, Highland Capital Management LLC, and Security National Bank.
View insider buying and selling activity for Hologic
.

How do I buy shares of Hologic?

Shares of HOLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Hologic's stock price today?

One share of HOLX stock can currently be purchased for approximately $68.82.

How big of a company is Hologic?

Hologic has a market capitalization of $17.82 billion and generates $3.37 billion in revenue each year. The medical equipment provider earns $-203,600,000.00 in net income (profit) each year or $2.43 on an earnings per share basis. Hologic employs 6,478 workers across the globe.

What is Hologic's official website?

The official website for Hologic is www.hologic.com.

How can I contact Hologic?

Hologic's mailing address is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at 508-263-2900 or via email at [email protected]

This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.